These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

225 related items for PubMed ID: 31339286

  • 21. Efficacy of Inhaled Treprostinil on Multiple Disease Progression Events in Patients with Pulmonary Hypertension due to Parenchymal Lung Disease in the INCREASE Trial.
    Nathan SD, Tapson VF, Elwing J, Rischard F, Mehta J, Shapiro S, Shen E, Deng C, Smith P, Waxman A.
    Am J Respir Crit Care Med; 2022 Jan 15; 205(2):198-207. PubMed ID: 34767495
    [Abstract] [Full Text] [Related]

  • 22. Pulmonary artery hypertension in formerly premature infants with bronchopulmonary dysplasia: clinical features and outcomes in the surfactant era.
    Khemani E, McElhinney DB, Rhein L, Andrade O, Lacro RV, Thomas KC, Mullen MP.
    Pediatrics; 2007 Dec 15; 120(6):1260-9. PubMed ID: 18055675
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Pulmonary hypertension specific treatment in infants with bronchopulmonary dysplasia.
    Kadmon G, Schiller O, Dagan T, Bruckheimer E, Birk E, Schonfeld T.
    Pediatr Pulmonol; 2017 Jan 15; 52(1):77-83. PubMed ID: 27333438
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Oral treprostinil in the treatment of pulmonary arterial hypertension.
    Feldman J, Habib N, Radosevich J, Dutt M.
    Expert Opin Pharmacother; 2017 Oct 15; 18(15):1661-1667. PubMed ID: 28922964
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. The prostacyclin pathway in pulmonary arterial hypertension: a clinical review.
    Del Pozo R, Hernandez Gonzalez I, Escribano-Subias P.
    Expert Rev Respir Med; 2017 Jun 15; 11(6):491-503. PubMed ID: 28399721
    [Abstract] [Full Text] [Related]

  • 37. [Treprostinil therapy for distal chronic thromboembolic pulmonary hypertension].
    Szafran B, Lewczuk J, Mazij M, Piszko P, Lenartowska L, Sośnik K, Wrabec K.
    Kardiol Pol; 2008 Feb 15; 66(2):183-6. PubMed ID: 18344157
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Oral treprostinil for the treatment of pulmonary arterial hypertension in patients on background endothelin receptor antagonist and/or phosphodiesterase type 5 inhibitor therapy (the FREEDOM-C study): a randomized controlled trial.
    Tapson VF, Torres F, Kermeen F, Keogh AM, Allen RP, Frantz RP, Badesch DB, Frost AE, Shapiro SM, Laliberte K, Sigman J, Arneson C, Galiè N.
    Chest; 2012 Dec 15; 142(6):1383-1390. PubMed ID: 22628490
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.